Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma

Journal: Nature Communications

Published: 2020-02-14

DOI: 10.1038/s41467-020-14639-9

Affiliations: 8

Authors: 18

Go to article
Institutions Share
Department of Molecular Cell Biology, WIS, Israel 0.50
NIH National Cancer Institute (NCI), United States of America (USA) 0.14
Faculty of Biology, IIT, Israel 0.11
Department of Veterinary Resources, WIS, Israel 0.06
NIH NCI Surgery Branch, United States of America (USA) 0.06
Sharett Institute of Oncology, HUJI, Israel 0.06
Nancy and Stephen Grand Israel National Center for Personalized Medicine (INCPM), WIS, Israel 0.06
Samsung Medical Center (SMC), South Korea 0.03

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER